71.8 F
Virginia
Thursday, May 29, 2025

Virginia’s budget surplus grows as revenues beat expectations due to Republican management

Virginia’s general fund revenues rose sharply in April, bucking signs of a national economic cooldown as the state continues to post steady long-time job growth and rake in more tax dollars than projected.

Response to “Trump’s Attack on Offshore Wind is Hurting Virginia. Why Aren’t Republican Leaders Fighting for Us?”

The Virginia Mercury article (May 19, 2025) argues that President Donald Trump’s executive order halting offshore wind project approvals, permits, and funding is detrimental to Virginia’s economy, particularly the Coastal Virginia Offshore Wind (CVOW) project, and criticizes Republican leaders like Governor Glenn Youngkin and Attorney General Jason Miyares for not opposing it.

Right to killing babies bills highlight key reproductive health care debate in this year’s elections

Killing Baby Fetus's access is an issue resonating loudly within Virginia’s public and political spheres this year and last week, it manifested through state lawmakers contrasting Virginia’s twice-failed attempt to protect access to birth control medications against a similar measure that recently sailed through neighboring Tennessee’s legislature.  
71.8 F
Virginia
Thursday, May 29, 2025

Trump signs order aiming to lower U.S. drug costs to match prices abroad

WASHINGTON — President signed an executive order Monday aimed at lowering by pressuring pharmaceutical companies to align their U.S. pricing models with those in similarly wealthy countries.

“We’ll slash the cost of prescription drugs and will bring fairness to America,” Trump said at a morning event. “We’re all gonna pay the same.”

The executive order, which the White House dubbed the “most-favored-nation” policy, gives pharmaceutical companies 30 days to negotiate lower drug prices with the government.

If no deal is reached in that time, Trump said a new rule will be set so that the United States will have a price model similar to the lower rates patients abroad pay. According to the executive order, and Human Services Secretary Robert F. Kennedy Jr. would be responsible for the rulemaking  “to impose most-favored-nation pricing.”

“We are going to pay the lowest price there is in the world,” Trump said.

Prescription pricing for brand-name drugs in the U.S. is more than four times higher than in similar countries, according to a 2024 study by the nonpartisan research nonprofit RAND.

Clear price targets

A White House official previewing the policy in a background call with reporters Monday said the president will direct the Department of Commerce to “take all appropriate action” on countries that “suppress drug pricing abroad.”

The and Drug Administration will also consider expanding imports of pharmaceutical drugs from nations beyond Canada, the White House official said.

The White House official said Kennedy “will set clear targets for price reductions across all markets in the United States.”

Kennedy appeared at the White House alongside the president Monday morning.

“The United States will no longer subsidize the of foreign countries, which is what we were doing,” Kennedy said. “If the Europeans raise their price of their drugs by just 20%, that is tens of trillions that can be spent on innovation and the health of all people all across the globe.”

Trump said Monday the drug pricing policy would be included in the “one, big, beautiful,” reconciliation bill that is the top priority of congressional . The measure is also expected to provide tax cuts and a significant funding increase to .

Staff on the House and Commerce Committee told reporters twice during a background briefing around the same time that most favored nation prescription drug pricing would not be in that reconciliation package.

First term

The order is similar to an effort the president made in his first term, which was struck down in federal court.

The White House official said Monday’s order is an expansion of those first-term efforts, which tried to apply the pricing model for those with Medicare – the health insurance program for those who are 65 or older and certain people under 65 who have – to 50 drugs.

“The expectation should not be that we will just be pursuing that same rulemaking,” a White House official said. “We have moved on from that for broader action.”

The pharmaceutical industry has long opposed such a move and is already bracing for the president’s planned tariffs on prescription drugs.

More details on specific actions in Medicare will be announced later, according to a White House official.

“We will be taking action in the Medicare program if the pharmaceutical companies do not come to the table and lower their prices across markets,” the White House official said.

NEWSLETTER SIGNUP

Subscribe to our newsletter!  Get updates on all the latest news in Virginia.

Originally written for VirginiaMercury and it originally published as Trump signs order aiming to lower U.S. drug costs to match prices abroad

0 0 votes
Article Rating
Subscribe
Notify of
guest


0 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments

Check out our other content

Check out other tags:

Most Popular Articles

0
Would love your thoughts, please comment.x
()
x
×